Alx Oncology Holdings (ALXO) Other Non-Current Liabilities (2019 - 2026)

Alx Oncology Holdings has reported Other Non-Current Liabilities for 8 years, with the latest figure at $3.5 million in Q1 2026.

• Quarterly Other Non-Current Liabilities fell 37.7% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 37.7% YoY) and the FY2025 annual result came in at $4.0 million, down 35.68% from the prior year.
• Other Non-Current Liabilities eased to $3.5 million in Q1 2026 per ALXO's latest filing, from $4.0 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $7.2 million in Q4 2023 and troughed at $3.5 million in Q1 2026.
• A 5-year average of $5.7 million and a median of $5.7 million in 2022 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities soared 1506.73% in 2022, then sank 37.7% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $5.3 million in 2022, then soared by 35.59% to $7.2 million in 2023, then retreated by 14.07% to $6.2 million in 2024, then tumbled by 35.68% to $4.0 million in 2025, then fell by 11.86% to $3.5 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.5 million, $4.0 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.